Literature DB >> 22067986

Development of a bedside tool to predict time to death after withdrawal of life-sustaining therapies in infants and children.

Paul M Shore1, Rong Huang, Lonnie Roy, Cindy Darnell, Heather Grein, Tammy Robertson, Lisa Thompson.   

Abstract

OBJECTIVES: To generate a preliminary bedside predictor of rapid time-to-death after withdrawal of support in children to help identify potential candidates for organ donation after circulatory death.
DESIGN: Retrospective chart review.
SETTING: Pediatric intensive care unit of an academic children's hospital. PATIENTS: All deaths in the pediatric intensive care unit from May 1996 to April 2007.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Among 1389 deaths, 634 patients underwent withdrawal of support and 518 with complete data regarding demographics, life-supportive therapies, and end-of-life circumstances were analyzed. Three hundred seventy-three (72%) patients died within 30 mins of withdrawal and 452 (87%) died within 60 mins. Using multiple logistic regression, significant predictors of death within 30 or 60 mins (typical cut-off times for organ donation) were identified and a predictor score was generated. Significant predictors included: age 1 month or younger; norepinephrine, epinephrine, or phenylephrine >0.2 µg/kg/min; extracorporeal membrane oxygenation; and positive end-expiratory pressure >10 cmH2O; and spontaneous ventilation. Possible scores for the 30-min predictor ranged from -17 to 67; a score ≤-9 predicted a 37% probability of death ≤ 30 mins, whereas a score ≥ 38 predicted an 85% probability of death within 30 mins. For the 60-min predictor, scores ranged from -21 to 38; score ≤-10 predicted a 59% probability of death within 60 mins and a score ≥ 16 predicted a 98% probability of death within 60 mins.
CONCLUSIONS: This tool is a reasonable preliminary predictor for death within 30 or 60 mins after withdrawal of support in terminally ill or injured children and might assist in identifying potential pediatric candidates for donation after circulatory death, although prospective validation is required.

Entities:  

Mesh:

Year:  2012        PMID: 22067986     DOI: 10.1097/PCC.0b013e318238b830

Source DB:  PubMed          Journal:  Pediatr Crit Care Med        ISSN: 1529-7535            Impact factor:   3.624


  5 in total

Review 1.  Predicting time to death after withdrawal of life-sustaining therapy.

Authors:  Laveena Munshi; Sonny Dhanani; Sam D Shemie; Laura Hornby; Genevieve Gore; Jason Shahin
Journal:  Intensive Care Med       Date:  2015-05-06       Impact factor: 17.440

2.  Validation of a pediatric bedside tool to predict time to death after withdrawal of life support.

Authors:  Ashima Das; Ingrid M Anderson; David G Speicher; Richard H Speicher; Steven L Shein; Alexandre T Rotta
Journal:  World J Clin Pediatr       Date:  2016-02-08

3.  Canadian Guidelines for Controlled Pediatric Donation After Circulatory Determination of Death-Summary Report.

Authors:  Matthew J Weiss; Laura Hornby; Bram Rochwerg; Michael van Manen; Sonny Dhanani; V Ben Sivarajan; Amber Appleby; Mary Bennett; Daniel Buchman; Catherine Farrell; Aviva Goldberg; Rebecca Greenberg; Ram Singh; Thomas A Nakagawa; William Witteman; Jill Barter; Allon Beck; Kevin Coughlin; Alf Conradi; Cynthia Cupido; Rosanne Dawson; Anne Dipchand; Darren Freed; Karen Hornby; Valerie Langlois; Cheryl Mack; Meagan Mahoney; Deepak Manhas; Christopher Tomlinson; Samara Zavalkoff; Sam D Shemie
Journal:  Pediatr Crit Care Med       Date:  2017-11       Impact factor: 3.624

Review 4.  Predicting Time to Death After Withdrawal of Life-Sustaining Treatment in Children.

Authors:  Meredith C Winter; David R Ledbetter
Journal:  Crit Care Explor       Date:  2022-09-08

5.  Palliative extubation: five-year experience in a pediatric hospital.

Authors:  Carolina de Araújo Affonseca; Luís Fernando Andrade de Carvalho; Renata de Pinho Barroso Quinet; Maíla Cristina da Cunha Guimarães; Verônica Ferreira Cury; Alexandre Tellechea Rotta
Journal:  J Pediatr (Rio J)       Date:  2019-09-04       Impact factor: 2.990

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.